Características epidemiológicas, clínicas y bacteriológicas de meningitis neumocócica en pacientes pediátricos de Lima, Perú

Davalos, Long; Terrazas, Yessica; Quintana, Ana; Egoavil, Martha; Sedano, Katherine; Castillo, María E.; Reyes, Isabel; Chaparro, Eduardo; Silva, Wilda; Campos, Francisco; Saenz, Andrés; Hernandez, Roger; Águila, Olguita del; Pinto, Daniel Guillén; Ochoa, Theresa J..
Rev. peru. med. exp. salud publica ; 33(3): 425-431, jul.-sep. 2016. tab
Artículo en Español | LILACS, LIPECS | ID: lil-798211

Documentos relacionados

  1. [Epidemiologic, clinical and bacteriologic characteristics of pneumococcal meningitis in pediatric patients from Lima, Peru].
  2. [Burden of Pneumococcal Meningitis and Bacteremia, Serotype Distribution and Antibiotic Resistance in Healthy Children After Conjugated Pneumococcal Vaccine Implementation: Single Center Experience].
  3. Risk factors and pathogen characteristics associated with unfavorable outcomes among adults with pneumococcal meningitis in Japan, 2006 to 2016.
  4. Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.
  5. Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine.
  6. Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease.
  7. Hearing outcomes in children with pneumococcal meningitis in the PCV13 era.
  8. Pneumococcal Meningitis Outbreaks in Africa, 2000-2018: Systematic Literature Review and Meningitis Surveillance Database Analyses.
  9. Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan.
  10. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.